Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Dec;74(3):317-20.

Immunologic abnormalities related to antigenaemia during HIV-1 infection

Affiliations

Immunologic abnormalities related to antigenaemia during HIV-1 infection

P De Paoli et al. Clin Exp Immunol. 1988 Dec.

Abstract

The expression of phenotypic markers on T and B lymphocytes in long-term human immunodeficiency virus type 1 (HIV-1) seropositive, antigen negative patients, in seropositive, antigen positive individuals without AIDS and in seronegative intravenous drug abusers was examined by two colour flow cytometry. Seropositive, antigen positive patients showed decreased CD4+ lymphocyte numbers, causing lower CD4/CD8 ratios when compared to seropositive, antigen negative subjects. While CD4 CDw29+ (4B4) lymphocytes are selectively reduced in seropositive, antigen negative individuals, both CD4 CDw29+ and CD4 CD45R+ (2H4) lymphocytes are decreased when antigenaemia is present. An increased percentage of CD3 HLA DR+ activated T lymphocytes and of CD20+ (B1) Leu 8 negative activated B cells was seen in HIV-1 seropositive antigen positive patients. These results demonstrate that, in long-term seropositive individuals, antigenaemia is associated with peculiar phenotypic changes of lymphocyte subsets.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Methods Enzymol. 1983;92:377-91 - PubMed
    1. J Immunol. 1988 Mar 1;140(5):1435-41 - PubMed
    1. Science. 1984 May 4;224(4648):497-500 - PubMed
    1. Science. 1984 Jul 6;225(4657):63-6 - PubMed
    1. J Immunol. 1984 Nov;133(5):2461-8 - PubMed

MeSH terms

Substances

LinkOut - more resources